Keywords: map, pharma, completes, 30m, finance, round, usa-based

MAP Pharma completes $30M finance round

Article | 20 September 2004

USA-based MAP Pharmaceuticals says it has closed a $30 million Series Bpreferred stock financing round, led by Pequot Ventures, Bay City ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in